Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Korea.
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Surg Endosc. 2024 May;38(5):2726-2733. doi: 10.1007/s00464-024-10782-2. Epub 2024 Mar 26.
Most gastric leiomyomas are asymptomatic and benign subepithelial tumors (SETs); however, some may increase in size or become symptomatic. Understanding their natural history is therefore important to their management. We investigated the natural history of histologically proven gastric leiomyomas.
We retrospectively reviewed histologically proven gastric leiomyoma cases at a tertiary center. The baseline characteristics of these cases were analyzed, and those with a follow-up period of at least 12 months without immediate resection were evaluated. The primary outcome was the frequency of size increase of more than 25% during the follow-up period, and the secondary outcome was the histopathologic results in cases that underwent resection.
Among the 231 patients with histologically proven gastric leiomyomas, the most frequent location was the cardia (77.1%), and the median size was 3 cm (IQR 2-4 cm). Eighty-four cases were followed up over a median period of 50.8 months (IQR 27.2-91.3 months). During the follow-up period, tumor size increased in two cases (2.4%). Surgical results showed that one case was leiomyoma, and the other was leiomyosarcoma. Among the remaining cases without change in size, 15 underwent surgical resection (n = 10) or endoscopic resection (n = 5), and all cases were confirmed as leiomyoma.
Most gastric leiomyomas are benign SETs, and an increase in size is not frequent, even in large-sized cases. Close monitoring with routine follow-up without resection may be sufficient in cases of histologically proven gastric leiomyoma. However, in cases of ulceration or size increase, resection may be beneficial.
大多数胃平滑肌瘤是无症状的良性黏膜下肿瘤(SETs);然而,有些可能会增大或出现症状。因此,了解其自然史对于其治疗非常重要。我们研究了组织学证实的胃平滑肌瘤的自然史。
我们回顾性分析了一家三级中心组织学证实的胃平滑肌瘤病例。分析这些病例的基线特征,并对至少随访 12 个月且无立即切除的病例进行评估。主要结局是在随访期间大小增加超过 25%的频率,次要结局是切除病例的组织病理学结果。
在 231 例组织学证实的胃平滑肌瘤患者中,最常见的部位是贲门(77.1%),中位大小为 3cm(IQR 2-4cm)。84 例患者中位随访时间为 50.8 个月(IQR 27.2-91.3 个月)。在随访期间,有 2 例(2.4%)肿瘤大小增大。手术结果显示 1 例为平滑肌瘤,另 1 例为平滑肌肉瘤。在其余大小无变化的病例中,有 15 例行手术切除(n=10)或内镜切除(n=5),所有病例均证实为平滑肌瘤。
大多数胃平滑肌瘤是良性的 SETs,即使是大型肿瘤,大小增大也不常见。对于组织学证实的胃平滑肌瘤,密切监测并常规随访而不切除可能足够。然而,在溃疡或大小增大的情况下,切除可能有益。